EP1429782A4 - Modulation of vitamin storage - Google Patents

Modulation of vitamin storage

Info

Publication number
EP1429782A4
EP1429782A4 EP02799356A EP02799356A EP1429782A4 EP 1429782 A4 EP1429782 A4 EP 1429782A4 EP 02799356 A EP02799356 A EP 02799356A EP 02799356 A EP02799356 A EP 02799356A EP 1429782 A4 EP1429782 A4 EP 1429782A4
Authority
EP
European Patent Office
Prior art keywords
modulation
vitamin storage
vitamin
storage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP02799356A
Other languages
German (de)
French (fr)
Other versions
EP1429782A1 (en
Inventor
Simon Michael West
David Kannar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vital Health Sciences Pty Ltd
Original Assignee
Vital Health Sciences Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/AU2001/001206 external-priority patent/WO2002026238A1/en
Priority claimed from AU2002951045A external-priority patent/AU2002951045A0/en
Application filed by Vital Health Sciences Pty Ltd filed Critical Vital Health Sciences Pty Ltd
Publication of EP1429782A1 publication Critical patent/EP1429782A1/en
Publication of EP1429782A4 publication Critical patent/EP1429782A4/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP02799356A 2001-09-26 2002-09-26 Modulation of vitamin storage Ceased EP1429782A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
PCT/AU2001/001206 WO2002026238A1 (en) 2000-09-26 2001-09-26 Phosphate derivative supplements
WOPCT/AU01/01206 2001-09-26
AU2002951045 2002-08-27
AU2002951045A AU2002951045A0 (en) 2002-08-27 2002-08-27 Method of supplementing nascent endogenous storage forms
PCT/AU2002/001321 WO2003026673A1 (en) 2001-09-26 2002-09-26 Modulation of vitamin storage

Publications (2)

Publication Number Publication Date
EP1429782A1 EP1429782A1 (en) 2004-06-23
EP1429782A4 true EP1429782A4 (en) 2005-02-02

Family

ID=25613914

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02799356A Ceased EP1429782A4 (en) 2001-09-26 2002-09-26 Modulation of vitamin storage

Country Status (5)

Country Link
EP (1) EP1429782A4 (en)
JP (1) JP2005515969A (en)
CA (1) CA2458279A1 (en)
MX (1) MXPA04001779A (en)
WO (1) WO2003026673A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
JP4690305B2 (en) * 2003-01-17 2011-06-01 バイタル ヘルス サイエンシズ プロプライアタリー リミティド Compounds with antiproliferative properties
US20060281716A1 (en) * 2004-03-03 2006-12-14 West Simon M Alkaloid formulations
ATE494911T1 (en) * 2004-08-03 2011-01-15 Vital Health Sciences Pty Ltd CARRIER FOR ENTERAL ADMINISTRATION
AU2006220248B2 (en) * 2005-03-03 2012-06-21 Vital Health Sciences Pty Ltd Compounds having lipid lowering properties
US20090233881A1 (en) * 2005-03-03 2009-09-17 Vital Health Sciences Pty. Ltd Compounds having anti-cancer properties
JP5221343B2 (en) 2005-06-17 2013-06-26 バイタル ヘルス サイエンシズ プロプライアタリー リミティド Carrier
AU2011213557B2 (en) 2010-02-05 2015-05-07 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
CA2788675C (en) * 2010-02-05 2018-01-16 Phosphagenics Limited Carrier composition
EP2552486B1 (en) 2010-03-30 2020-08-12 Phosphagenics Limited Transdermal delivery patch
US9561243B2 (en) 2011-03-15 2017-02-07 Phosphagenics Limited Composition comprising non-neutralised tocol phosphate and a vitamin A compound
WO2017096427A1 (en) 2015-12-09 2017-06-15 Phosphagenics Limited Pharmaceutical formulation
EP3558903A4 (en) 2016-12-21 2019-11-27 Avecho Biotechnology Limited Process

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0430045A2 (en) * 1989-11-21 1991-06-05 Senju Pharmaceutical Co., Ltd. Ascorbic acid tocopheryl phosphate diesters for inhibition of Maillard's reaction
US5607921A (en) * 1994-01-31 1997-03-04 L'oreal Stabilized cosmetic or dermatological composition containing several precursors of the same active agent in order to maximize its release, and use thereof
US5776915A (en) * 1997-08-12 1998-07-07 Clarion Pharmaceuticals Inc. Phosphocholines of retinoids
JPH1143436A (en) * 1997-07-25 1999-02-16 Showa Denko Kk Medicine for preventing/treating periphery blood stream disorder
JPH11199424A (en) * 1997-12-26 1999-07-27 Nonogawa Shoji Kk Skin preparation for external use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114957A (en) * 1990-05-08 1992-05-19 Biodor U.S. Holding Tocopherol-based antiviral agents and method of using same
FR2679904A1 (en) * 1991-08-01 1993-02-05 Lvmh Rech Use of a tocopherol phosphate, or of one of its derivatives, in the preparation of cosmetic or pharmaceutical compositions and compositions thus obtained
US5643597A (en) * 1991-08-01 1997-07-01 Lvmh Recherche Use of a tocopherol phosphate or one of its derivatives for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained
WO1993015731A1 (en) * 1992-02-14 1993-08-19 Robert Lamb Phosphate derivatives of vitamin e to protect cells from effects of aging and injury
JPH05286848A (en) * 1992-04-10 1993-11-02 Senju Pharmaceut Co Ltd Bathing agent
JP3362501B2 (en) * 1994-04-28 2003-01-07 千寿製薬株式会社 Corneal disorder treatment
JPH10155429A (en) * 1996-11-27 1998-06-16 Showa Denko Kk Method for supplying vitamin e to animals and tocopherol phosphate for animals or its salts composition
WO2002026238A1 (en) * 2000-09-26 2002-04-04 Vital Health Sciences Pty Ltd. Phosphate derivative supplements

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0430045A2 (en) * 1989-11-21 1991-06-05 Senju Pharmaceutical Co., Ltd. Ascorbic acid tocopheryl phosphate diesters for inhibition of Maillard's reaction
US5607921A (en) * 1994-01-31 1997-03-04 L'oreal Stabilized cosmetic or dermatological composition containing several precursors of the same active agent in order to maximize its release, and use thereof
JPH1143436A (en) * 1997-07-25 1999-02-16 Showa Denko Kk Medicine for preventing/treating periphery blood stream disorder
US5776915A (en) * 1997-08-12 1998-07-07 Clarion Pharmaceuticals Inc. Phosphocholines of retinoids
JPH11199424A (en) * 1997-12-26 1999-07-27 Nonogawa Shoji Kk Skin preparation for external use

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 1999, no. 05 31 May 1999 (1999-05-31) *
PATENT ABSTRACTS OF JAPAN vol. 1999, no. 12 29 October 1999 (1999-10-29) *
See also references of WO03026673A1 *

Also Published As

Publication number Publication date
WO2003026673A1 (en) 2003-04-03
MXPA04001779A (en) 2004-05-31
EP1429782A1 (en) 2004-06-23
JP2005515969A (en) 2005-06-02
CA2458279A1 (en) 2003-04-03

Similar Documents

Publication Publication Date Title
AU2002255329A1 (en) Stable solution of reduced coenzyme Q
HK1067907A1 (en) Amplifier modulation
TW487177U (en) Anti-dust lid of connecting slot
HUP0401534A3 (en) Modified factor ix
AU2002244203A1 (en) Devices and methods for prolonging the storage life of produce
TW509023U (en) Cosmetic case
EP1429782A4 (en) Modulation of vitamin storage
AU2003252072A8 (en) Modulation of protein kinase c-iota expression
AU2002366788A1 (en) Antisense modulation of ship-1 expression
AU2002318139A1 (en) Antisense modulation of src-c expression
GB0126781D0 (en) Modulation
GB0124321D0 (en) Modulation determination
AU2002357102A1 (en) Antisense modulation of cd36l1 expression
AU2003257966A1 (en) Antisense modulation of lar expression
IL162747A0 (en) Modulation of heat-shock-protein-based immunotherapies
AU2003295790A8 (en) Modulation of iap-like expression
AU2002322551A1 (en) Antisense modulation of rip2 expression
AU2003290966A8 (en) Modulation of nima-related kinase 6 expression
AU2002347809A1 (en) Antisense modulation of inhibitor-kappa b kinase-gamma expression
AU2003290763A8 (en) Modulation of jumonji expression
GB0106857D0 (en) Storage
AU2002329838A1 (en) Modulation of appl expression
AU2002244086A1 (en) Antisense modulation of recql4 expression
WO2003048376A9 (en) Modulation of immune-cell related disorders using il-1hy2
AU2002362942A1 (en) Modulation of tor

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040323

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20041221

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20070708